Latest News

What next for payment reform? February 20, 2019

There may not have been any formal discussions on the proposed changes to supply chain payments for around three months but that has not stopped key stakeholder groups from working on the delayed reform.

New report calls for greater focus on secondary CV events February 20, 2019

A new report developed by the Baker Heart and Diabetes Institute and sponsored by Bayer will be launched in Canberra today.

Fee 'crunch' for smaller companies and patient populations February 20, 2019

Smaller companies are raising specific concerns about the new PBS and vaccine cost recovery arrangements.

Partnership to manage Biomedical Translation Bridge Program February 20, 2019

The federal government has announced that a partnership between BioCurate, MTPConnect, UniQuest and the Medical Device Partnering Program, will operate the $22.3 million Biomedical Translation Bridge (BTB) Program.

Gilead's Rob Hetherington: 'Workplaces have come such a long way' February 19, 2019

Gilead Sciences has become a sponsor and official partner of the Sydney Gay and Lesbian Mardi Gras in 2019.

Department of Health reveals facts on key listing stage February 19, 2019

The Department of Health has revealed the average time between PBAC recommendation and the finalisation of price and cost agreements with companies.

Response reveals impact of higher price cut threshold February 19, 2019

77 medicines did not take a price disclosure reduction in October 2018 because of a higher threshold negotiated as part of reforms announced in 2017-18.

ST Asia announces new special access program February 19, 2019

Melbourne-based Specialised Therapeutics Asia has announced a program that will provide patients in Singapore with early access to its new breast cancer therapy.

BMS' Davide Piras: The 'challenge' in Australia is not 'dramatically different' February 18, 2019

Davide Piras has a truly global role for Bristol-Myers Squibb, leading the company's business in Europe, Canada and Australia while living in the US.

Two weeks to go as #PharmaCup2019 races towards record February 18, 2019

The companies have raised around $17,000 in the past week, with their combined total more than double compared to the same period last year, as they work to break last year's record of $86,000 and reach the goal of $100,000.

New deputy chair for Medicines Australia February 18, 2019

A new deputy chair for Medicines Australia with Pfizer's Melissa McGregor appointed to the role previously held by current chair Dr Anna Lavelle.

Department to pay for Labor's Health Reform Commission February 15, 2019

The requirement to offset the cost of the new commission could reduce cost the Department around 5 per cent of its annual appropriation based on the cost of running the Productivity Commission.

Latest Video

Most Read

Department of Health reveals facts on key listing stage

BMS' Davide Piras: The 'challenge' in Australia is not 'dramatically different'

Gilead's Rob Hetherington: 'Workplaces have come such a long way'

New deputy chair for Medicines Australia

Fee 'crunch' for smaller companies and patient populations

New Stories

What next for payment reform?

New report calls for greater focus on secondary CV events

Fee 'crunch' for smaller companies and patient populations

Partnership to manage Biomedical Translation Bridge Program

Gilead's Rob Hetherington: 'Workplaces have come such a long way'

Department of Health reveals facts on key listing stage

Response reveals impact of higher price cut threshold

Sign In

Latest Video

Most Read

Department of Health reveals facts on key listing stage

BMS' Davide Piras: The 'challenge' in Australia is not 'dramatically different'

Gilead's Rob Hetherington: 'Workplaces have come such a long way'

New deputy chair for Medicines Australia

Fee 'crunch' for smaller companies and patient populations

Follow Us

New Stories

What next for payment reform?

New report calls for greater focus on secondary CV events

Fee 'crunch' for smaller companies and patient populations

Partnership to manage Biomedical Translation Bridge Program

Gilead's Rob Hetherington: 'Workplaces have come such a long way'

Department of Health reveals facts on key listing stage

Response reveals impact of higher price cut threshold